SCHEMBL32690841

SCHEMBL32690841

COC(=O)CCc1ccc(S(=O)(=O)Nc2ccc3c(=O)c(O)c(-c4ccccc4C(F)(F)F)[nH]c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.41
▸ FABP5 Q01469 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ AURKB Q96GD4 1/20 0.38
▸ FFAR4 Q5NUL3 2/20 0.37
▸ BRD4 O60885 2/20 0.37
▸ BACE1 P56817 2/20 0.37
▸ CCR9 P51686 1/20 0.37
▸ POLB P06746 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690703 0.90 HDAC1 (0.48) MEN1KMT2AFFAR4POLBTP53
SCHEMBL32690723 0.86 POLB (0.44) FABP5MEN1KMT2AFFAR4BRD4
SCHEMBL32690754 0.84 FFAR4 (0.48) FFAR4BRD4POLBHSP90AA1HSP90AB1
SCHEMBL32690856 0.83 HDAC1 (0.40) FABP5MEN1KMT2ABRD4MAPT
SCHEMBL32690778 0.82 HDAC6 (0.42) MEN1KMT2AFFAR4BRD4MAPT
SCHEMBL32690791 0.82 MAPT (0.42) FABP5MEN1KMT2ABRD4POLB
SCHEMBL32690721 0.80 PTPRC (0.49) TDP1
SCHEMBL32690793 0.79 HDAC1 (0.48) HDAC4HDAC1HDAC8
SCHEMBL32690859 0.79 MAP4K4 (0.46) MEN1KMT2AAURKBFFAR4BRD4
SCHEMBL32690676 0.79 PTPRC (0.51) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB IDO1 2749/4885FABP5 4243/4885MEN1 4795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback